Berkshire Hathaway announced it sold 203,091 shares of DaVita Inc., reducing its ownership stake in the kidney dialysis services provider. This transaction decreased Berkshire's holding to approximately 35.89 million shares.
The sale resulted in Berkshire Hathaway holding a 45% stake in DaVita, valued at nearly $6.4 billion. This divestment was part of a preplanned share repurchase agreement that the two parties had established in April.
The reduction in stake by a major, long-term investor like Berkshire Hathaway can be interpreted by the market as a significant event, potentially influencing investor sentiment regarding DaVita's future prospects.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.